Nov. 6, 2012
/PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company based in
, announced today that
has joined the company as VP of Commercial Operations. Mr. Rowland is an industry veteran who started his career starting as a sales representative for UCB Pharmaceuticals. He later held various marketing positions with UCB prior to taking the position of head of marketing for Scandipharm. He played a lead role in turning the Scandipharm business around prior to its sale to Axcan Pharmaceuticals. Thom then served as a VP of Sales and Marketing for several business units at Solvay Pharmaceuticals where he was again instrumental in turning around an underperforming area. Thom was one of the founders of Ventrus Biosciences which completed a successful IPO in 2010.
, President and CEO of Arbor, commented, "We are pleased that Thom has joined Arbor at this crucial time in our development as an organization. As our business grows and we become more complex, we felt it was essential that we have someone of Thom's level of experience on board. I'm confident Thom will optimize our current business as well as our future product launches."
Mr. Rowland added, "Arbor has achieved tremendous growth over its short history and is well positioned for future growth. I am pleased to be joining this highly productive organization at this exciting time and look forward to leading the commercial team to continued success."
About Arbor Pharmaceuticals, Inc.
Arbor Pharmaceuticals, headquartered in
, is a specialty pharmaceutical company currently focused on the cardiovascular, pediatric and hospital markets. The company intends to become a leading specialty pharmaceutical company by actively licensing, developing and commercializing late-stage products for specialty focused conditions. Arbor currently markets multiple NDA and ANDA approved products with several more in development.
For more information regarding Arbor Pharmaceuticals or any of its products, visit
or send email inquiries to